$ATEX

Anterix Inc (ATEX) Chief Legal Officer & Corp Sec Gena Ashe Sell

Anterix Inc (ATEX) Chief Legal Officer Gena Ashe sold 4,357 shares at $85.44 each, totaling $372,262. Ashe has sold 28,632 shares in the past year, with no purchases. Anterix has seen 13 insider sells vs. 3 buys in the last year. The stock trades at a P/E of 24.41, above industry and historical medians, and is deemed overvalued by GuruFocus.

Original reporting
Published Sep 9, 2026, 12:18 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 9, 2026, 5:19 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefFinancial news
Primary signal
$ATEX
Neutral
medium confidence
Mentioned
$ATEX
Relevance
4/10
AlphAI data visualization · based on gurufocus.com
Decision brief

The 30-second read

$ATEXNeutralLow
01

Why it matters

The insider sale adds a modest bearish data point amid a valuation premium; investors should weigh it against the company's growth narrative.

02

Market read

Primary relevance is limited to ATEX shareholders; the broader market impact is negligible.

03

What to watch

Potential upcoming contract announcements or regulatory changes could offset the negative signal from insider selling.

Relevance 4/10Novelty 3/10Timing: September 8, 2026 (SEC Form 4 filing date)

Background

Anterix provides private wireless broadband solutions using 900 MHz spectrum for critical infrastructure.

Company-level read

Ticker impact

$ATEXNeutralMedium confidence
Context

Chief Legal Officer Gena Ashe sold 4,357 shares at $85.44, reducing her stake to 5,174 shares.

Expected impact

Potential short-term pressure on ATEX shares, limited upside/downside impact.

Evidence & confidence

The sale represents a small fraction of float and occurs at a price above intrinsic value, suggesting limited immediate market reaction.

Market effects

Minimal; reflects broader insider selling trend in the telecom infrastructure niche.

None beyond ATEX.

Low; does not affect broader market indices.

Counterpoint

The sale could be a tactical move unrelated to fundamentals; investors may view the stock as still undervalued relative to growth prospects.

Key entities

  • Anterix Inc

    Provider of private LTE/5G solutions for utilities and industrial customers.

  • Gena Ashe

    Chief Legal Officer & Corporate Secretary of Anterix.

Related articles

$ATEXMed

Is Anterix (ATEX) Quietly Reframing Its Connectivity Moat With New 900 MHz FCC Flexibility?

Anterix (ATEX) gained attention after the FCC approved expanded 900 MHz broadband use and granted it a license for satellite testing. This could broaden its network applications and reinforce its investment narrative, though profitability currently relies heavily on noncash spectrum gains. Analysts project $6.9M revenue and $935K earnings by 2028, with a potential 36% downside from current prices.

$ATEXMed

Anterix (ATEX) Q1 2027 Earnings Call Transcript

Anterix (ATEX) reported Q1 2027 revenue of $2M, up from $1.4M YoY, with net income of $240K. Operating expenses decreased to $12.9M. The company has $116M in cash, no debt, and $226.7M left for share repurchases. Management highlighted 12 active deals, spectrum clearing progress, and support for SpaceX's FCC proposal. CFO warned of potential higher costs if spectrum clearing is accelerated.

$ATEXMed

Anterix Inc. (ATEX): Results of Operations and Financial Condition

Anterix Inc. (ATEX) filed an SEC Form 8-K — Results of Operations and Financial Condition. Anterix Inc. Reports First Quarter Fiscal Year 2027 Results Woodland Park, NJ – August 11, 2026 – Anterix (NASDAQ: ATEX) today announced its first quarter fiscal 2027 results and filed its Form 10-Q for the three months ended June 30, 2026. Financial and Operational Highlights –

$ATEXMed

Anterix Inc. (ATEX): Results of Operations and Financial Condition

Anterix Inc. (ATEX) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 atex-20260331xpressrelease.htm EX-99.1 Document Anterix Inc. Reports Full Fiscal Year 2026 Results Woodland Park, NJ – June 10, 2026 – Anterix (NASDAQ: ATEX) today announced fiscal 2026 fourth quarter and full fiscal year financial results for the year ended March 31, 2